Serum Levels of the C-terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients with Hemodialysis Undergoing Treatment with a Proline Hydroxylase Domain (PHD) Inhibitor
Crossref DOI link: https://doi.org/10.29328/journal.jcn.1001141
Published Online: 2024-10-14
Update policy: https://doi.org/10.29328/crossmark-policy
Motomiya, Yoshihiro
Kaneko, Yoshiteru
Motomiya, Yasuki
Higashimoto, Yuichiro
License valid from 2024-10-14
